KEY FEATURES
Full Name | Apoptosis Inducing Factor |
---|---|
Synonym | PDCD8; Programmed Cell Death protein 8; Apoptosis-inducing factor 1, mitochondrial |
Assay Type | Sandwich |
Reactivity | Human |
Range | 15.6-1000pg/mL |
Sensitivity | 5.5pg/mL |
Sample Type | Serum,plasma and other biological fluids |
Sample Volume | 100μL |
Detection Wavelength | OD450 |
Transportation Temperature | 2-8°C |
Specificity | The kit detected Human AIF in the samples and no significant cross-species reactions were found |
Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human AIF. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human AIF and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human AIF, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human AIF. You can calculate the concentration of Human AIF in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
Components | Specifications | Storage and Notes |
---|---|---|
Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Human AIF ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
Intra-assay Precision | Inter-assay Precision | |||||
---|---|---|---|---|---|---|
Sample | 1 | 2 | 3 | 1 | 2 | 3 |
n | 20 | 20 | 20 | 20 | 20 | 20 |
Mean (pg/mL) | 52.51 | 129.08 | 404.29 | 54.42 | 135.23 | 428.5 |
Standard deviation | 2.74 | 7.41 | 15.52 | 3.4 | 5.76 | 13.63 |
CV(%) | 5.22 | 5.74 | 3.84 | 6.24 | 4.26 | 3.18 |
RECOVERY
The recovery of Human AIF spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
Sample Type | Range (%) | Average Recovery (%) |
---|---|---|
Serum(n=8) | 87-103 | 94 |
EDTA plasma (n=8) | 93-108 | 98 |
Cell culture media (n=8) | 84-96 | 91 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human AIF in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with AIF ELISA Kits
CASP3 ELISA Kit | publications with AIF and CASP3 |
XIAP ELISA Kit | publications with AIF and XIAP |
ENDOG ELISA Kit | publications with AIF and ENDOG |
HSP72 ELISA Kit | publications with AIF and HSP72 |
Pathways associated with AIF ELISA Kit
Apoptosis Pathway | Apoptosis Pathway |
Apoptosis Modulation By HSP70 Pathway | Apoptosis Modulation By HSP70 Pathway |
Ceramide Signaling Pathway | Ceramide Signaling Pathway |
Diseases associated with AIF ELISA Kit
Necrosis | publications with AIF and Necrosis |
Nervous System Diseases | publications with AIF and Nervous System Diseases |
Brain Diseases | publications with AIF and Brain Diseases |
Breast Neoplasms | publications with AIF and Breast Neoplasms |
Carcinoma, Hepatocellular | publications with AIF and Carcinoma, Hepatocellular |
Liver Neoplasms | publications with AIF and Liver Neoplasms |
Neoplasms, Experimental | publications with AIF and Neoplasms, Experimental |
Heart Diseases | publications with AIF and Heart Diseases |
Disease Models, Animal | publications with AIF and Disease Models, Animal |
Inflammation | publications with AIF and Inflammation |
Organs/Tissues associated with AIF ELISA Kit
Blood | publications with AIF and Blood |
Brain | publications with AIF and Brain |
Lung | publications with AIF and Lung |
Liver | publications with AIF and Liver |
Muscle | publications with AIF and Muscle |
Vascular | publications with AIF and Vascular |
Heart | publications with AIF and Heart |
Prostate | publications with AIF and Prostate |
Skin | publications with AIF and Skin |
Stomach | publications with AIF and Stomach |